Previous Close | 1.2800 |
Open | 1.3000 |
Bid | 1.2400 x 4000 |
Ask | 1.3100 x 1100 |
Day's Range | 1.1500 - 1.3500 |
52 Week Range | 0.8000 - 8.8300 |
Volume | |
Avg. Volume | 770,256 |
Market Cap | 43.424M |
Beta (5Y Monthly) | 1.04 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.5150 |
Earnings Date | Feb 08, 2022 - Feb 14, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Apr 02, 2020 |
1y Target Est | 6.25 |
ELYRIA, Ohio, June 28, 2022--Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will participate in the 22nd Annual New Ideas Summer Conference on Tuesday, July 12, 2022.
ELYRIA, Ohio, June 07, 2022--Invacare Corporation (NYSE: IVC), a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced that Matt Monaghan, chairman, president and chief executive officer, will present at the 12th Annual East Coast IDEAS Investor Conference on Wednesday, June 22, 2022. The webcast of the presentation will be available at https://wsw.com/webcast/threepa37/ivc/ and it will be accessible for replay for 90 days following the confer
ELYRIA, Ohio, May 24, 2022--Invacare Corporation (NYSE: IVC) announced the U.S. introduction of its Birdie™ Evo XPLUS, an innovative patient lift solution for the post-acute care setting. With its sleek and modern design, the Birdie Evo XPLUS provides innovative technology that helps maximize comfort and security when lifting or transferring a patient to or from a bed, chair or floor.